{
    "nctId": "NCT02528604",
    "officialTitle": "Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study",
    "inclusionCriteria": "* Patients with symptomatic persistent atrial fibrillation of less than 1-year duration.\n* Patients must be over 65 years old.\n* Patients give informed consent prior to participating in this study.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Paroxysmal atrial fibrillation.\n* Long-standing persistent or permanent atrial fibrillation.\n* Previous pacemaker implantation.\n* Previous atrial ablation.\n* Patient is unable to take warfarin or other oral anti-coagulant medication.\n* Patient is suffering with unstable angina in last one week.\n* Patient has had a myocardial infarction within last two months.\n* Patient is expecting or has had major cardiac surgery within last two months.\n* Patient is participating in a conflicting study.\n* Patient is unable to perform exercise testing.\n* Patient is mentally incapacitated and cannot consent or comply with follow-up.\n* Patient has New York Heart Association (NYHA) class III/IV heart failure.\n* Patient has left ventricular ejection fraction (LVEF) less than 35% not secondary to tachycardia.\n* Pregnancy.\n* Patient suffers with other cardiac rhythm disorders.\n* Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings)."
}